Small compounds targeting TACC3
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 25, 2017
Grant Date -
Apr 23, 2015
app pub date -
Apr 30, 2013
filing date -
May 2, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a small compound targeting at TACC3. The present invention further provides a drug, particularly, an anticancer agent, comprising the small compound targeting at TACC3. A compound represented by the general formula (I) or a pharmaceutically acceptable salt, solvate, or ester derivative thereof binds to TACC3 and inhibits cell growth. Thus, these compounds can be used as drugs, particularly, anticancer agents.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully